IMVARIA Presents Multi-Site Clinical Data on AI Diagnostic Service for Idiopathic Pulmonary Fibrosis at ATS 2025

IMVARIA Inc. announced the presentation of multi-site clinical experience results with its FDA-authorized AI diagnostic service, Fibresolve, at the AT...
Home/KnloSights/Clinical Trial Updates/IMVARIA Presents Multi-Site Clinical Data on AI Diagnostic Service for Idiopathic Pulmonary Fibrosis at ATS 2025